A Review on Protein Misfolding Diseases and therapeutics for preventing Diseases
Background: Protein misfolding sicknesses are the gathering of irresistible lethal neuro and non-neurodegenerative infections and in ebb and flow researchers and specialists accepted that unusual folding of protein is the essential or main key of such illnesses are Alzheimer's infections, Parkinson's diseases, Huntington's sickness, Creutzfeldt-Jakob infection, cystic fibrosis, Gaucher's infection and numerous other degenerative and neurodegenerative problems. The motive of this review article is to gave a detailed of the existing structural information for prion and prion protein and also we will trying to find out their preventing root causes with respect to structural information of prions within the context of what is known about the protein misfolding diseases.
Objective: This article presents a brief overview of research on the use of these therapeutics for the treatment or improvement in prion diseases or protein misfolding.
Material and Methods: This article begins with the brief introduction about protein misfolding diseases or infections and the therapeutic materials which are used in researches or explain this article (pentosan polysulfate, Quinacrine, Doxycycline, Chaperone based therapy, Resveratrol and curcumin) etc.
Results and Conclusions: In this present context of protein misfolding/prion diseases diagonsis.Therapeutic approaches predicts that person infected with prion diseases prolongs the survival time of the patient and improvement in the conditions of the prion diseased infected patient which provides good result for future medicine development.
Keywords: Amyloid, Beta-sheet, neurodegenerative, prion, protein misfolding, therapeutics etc
2. Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A. N. A., Groth, D., ... & Cohen, F. E. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proceedings of the National Academy of Sciences, 1993; 90(23):10962-10966. https://doi.org/10.1073/pnas.90.23.10962
3. Scheinost, J. C., Boldt, G. E., & Wentworth, P. Protein Misfolding and Disease. Chemical Biology: Approaches to Drug Discovery and Development to Targeting Disease, 2012; 379-400. https://doi.org/10.1002/9781118435762.ch19
4. Rambaran, R. N., & Serpell, L. C. Amyloid fibrils: abnormal protein assembly. Prion, 2008; 2(3):112-117. https://doi.org/10.4161/pri.2.3.7488
5. Chen, C., & Dong, X. Therapeutic implications of prion diseases. Biosafety and Health. 2020.
6. Sweeney, P., Park, H., Baumann, M., Dunlop, J., Frydman, J., Kopito, R., Hodgson, R. Protein misfolding in neurodegenerative diseases: implications and strategies. Translational neurodegeneration, 2017; 6(1):1-13. https://doi.org/10.1186/s40035-017-0077-5
7. Nargeh, H., Aliabadi, F., Ajami, M., & Pazoki-Toroudi, H. Role of Polyphenols on Gut Microbiota and the Ubiquitin-Proteasome System in Neurodegenerative Diseases. Journal of Agricultural and Food Chemistry. 2021. https://doi.org/10.1021/acs.jafc.1c00923
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).